RxDoctor Payments DataLook up a doctor →

Sherry Soefje

Psychiatry · Oceanside, CANPI 1639260201

Payments from drug & device makers

$11,917,500in general payments, 2019–2025

Across 1,665 payments — averaging $7157.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2.9M
  • Teva Pharmaceuticals USA, Inc.$1.8M
  • Sage Therapeutics, LLC$1.1M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$961K
  • Bioxcel Therapeutics, Inc.$711K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$651K
  • plus $3.8M from 24 others
$5,754in research payments, 2019–2025

Across 38 payments — averaging $151.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
  • AbbVie$3K
  • Teva Pharmaceuticals USA, Inc.$76

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,917,500 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in Oceanside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →